Related Experiment Video
Updated: Jun 11, 2025

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
Osteoarthritis: Mechanistic Insights, Senescence, and Novel Therapeutic Opportunities
Paula Carpintero-Fernández1, Marta Varela-Eirín1,2, Alejandro García-Yuste1
1CellCOM Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Servizo Galego de Saúde (SERGAS), Universidade da Coruña (UDC), A Coruña, Spain.
Abstract:
Osteoarthritis (OA) is the most common joint disease. In the last years, the research community has focused on understanding the molecular mechanisms that led to the pathogenesis of the disease, trying to identify different molecular and clinical phenotypes along with the discovery of new therapeutic opportunities. Different types of cell-to-cell communication mechanisms have been proposed to contribute to OA progression, including mechanisms mediated by connexin43 (Cx43) channels or by small extracellular vesicles. Furthermore, changes in the chondrocyte phenotype such as cellular senescence have been proposed as new contributors of the OA progression, changing the paradigm of the disease. The use of different drugs able to restore chondrocyte phenotype, to reduce cellular senescence and senescence-associated secretory phenotype components, and to modulate ion channel activity or Cx43 appears to be promising therapeutic strategies for the different types of OA. In this review, we aim to summarize the current knowledge in OA phenotypes related with aging and tissue damage and the new therapeutic opportunities currently available.
Insights
Osteoarthritis (OA) involves aging and tissue damage, impacting joint health. New therapies target chondrocyte phenotype, senescence, and cell communication for OA treatment.
Area of Science:
- Biomedical Science
- Molecular Biology
- Gerontology
Background:
- Osteoarthritis (OA) is a prevalent joint disease with complex molecular mechanisms.
- Research is identifying distinct molecular and clinical OA phenotypes.
- Cell-to-cell communication and chondrocyte senescence are emerging as key disease drivers.
Purpose of the Study:
- To review current knowledge on OA phenotypes linked to aging and tissue damage.
- To explore emerging therapeutic opportunities for OA.
- To discuss the role of cell-to-cell communication and chondrocyte senescence in OA.
Main Methods:
- Literature review of recent research on OA pathogenesis.
- Analysis of studies on molecular mechanisms, including cell communication and senescence.
- Synthesis of information on therapeutic strategies targeting OA phenotypes.
Main Results:
- Cell-to-cell communication via connexin43 (Cx43) channels and extracellular vesicles contributes to OA.
- Cellular senescence and its associated secretory phenotype are significant factors in OA progression.
- Therapeutic strategies targeting chondrocyte phenotype restoration and senescence reduction show promise.
Conclusions:
- Understanding OA phenotypes related to aging and tissue damage is crucial.
- Modulating cell communication and chondrocyte senescence offers promising therapeutic avenues for OA.
- Targeting these mechanisms could lead to effective treatments for various OA types.
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Mitochondria
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
The JAK-STAT Signaling Pathway
The Effect of Aging on Tissues

